GRI Latest Press Releases

-- September 28, 2026 --

GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit Globe Newswire 8:40 AM

-- September 8, 2026 --

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars Globe Newswire 8:15 AM

-- August 27, 2026 --

JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs ACCESS Newswire 9:01 AM

GRI Bio Featured in "Why Now" On-Demand Video Webcast Globe Newswire 9:01 AM

-- August 24, 2026 --

GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026 Globe Newswire 9:05 AM

-- June 18, 2026 --

GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis Globe Newswire 8:31 AM

Market Data Delayed 15 Minutes